BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Molena D, Stem M, Blackford AL, Lidor AO. Esophageal Cancer Treatment Is Underutilized Among Elderly Patients in the USA. J Gastrointest Surg 2017;21:126-36. [PMID: 27527093 DOI: 10.1007/s11605-016-3229-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Toxopeus E, van der Schaaf M, van Lanschot J, Lagergren J, Lagergren P, van der Gaast A, Wijnhoven B. Outcome of Patients Treated Within and Outside a Randomized Clinical Trial on Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: Extrapolation of a Randomized Clinical Trial (CROSS). Ann Surg Oncol. 2018;25:2441-2448. [PMID: 29948420 DOI: 10.1245/s10434-018-6554-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
2 Raman V, Jawitz OK, Voigt SL, Rhodin KE, Kim AW, Tong BC, D'Amico TA, Harpole DH. Patterns of Care in Neoadjuvant Chemoradiotherapy for Node-Positive Esophageal Adenocarcinoma. Ann Thorac Surg 2020;110:1832-9. [PMID: 32622794 DOI: 10.1016/j.athoracsur.2020.05.069] [Reference Citation Analysis]
3 Madhavan A, Kamarajah SK, Navidi M, Wahed S, Immanuel A, Hayes N, Griffin SM, Phillips AW. The impact of age on patients undergoing transthoracic esophagectomy for cancer. Dis Esophagus. 2020;. [PMID: 32556151 DOI: 10.1093/dote/doaa056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Nobel TB, Lavery JA, Barbetta A, Gennarelli RL, Lidor AO, Jones DR, Molena D. National guidelines may reduce socioeconomic disparities in treatment selection for esophageal cancer. Dis Esophagus 2019;32:doy111. [PMID: 30496376 DOI: 10.1093/dote/doy111] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Schlottmann F, Gaber C, Strassle PD, Herbella FAM, Molena D, Patti MG. Disparities in esophageal cancer: less treatment, less surgical resection, and poorer survival in disadvantaged patients. Dis Esophagus 2020;33:doz045. [PMID: 31076759 DOI: 10.1093/dote/doz045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
6 Zheng C, Luo C, Xie K, Qiang Y, Wang GM, Shen Y. Distinguishing optimal esophagectomy candidates in elderly patients: A nomogram based on propensity score matching. Eur J Surg Oncol 2021:S0748-7983(21)00982-3. [PMID: 34952748 DOI: 10.1016/j.ejso.2021.12.016] [Reference Citation Analysis]
7 Schlottmann F, Strassle PD, Molena D, Patti MG. Influence of Patients' Age in the Utilization of Esophagectomy for Esophageal Adenocarcinoma. J Laparoendosc Adv Surg Tech A 2019;29:213-7. [PMID: 30362867 DOI: 10.1089/lap.2018.0434] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Raja S, Sudarshan M. Commentary: First Do No Harm But Also Don't Forget to Treat! Semin Thorac Cardiovasc Surg 2021:S1043-0679(21)00024-1. [PMID: 33600985 DOI: 10.1053/j.semtcvs.2020.12.018] [Reference Citation Analysis]
9 Conway P, Leach M, Tejani N, Robinson A, Shethia Y, Solo I. Oesophageal cancer treatment patterns, timeliness of care and outcomes in the Loddon Mallee region of Victoria: A retrospective cohort study. J Med Imaging Radiat Oncol 2021;65:242-50. [PMID: 33634598 DOI: 10.1111/1754-9485.13167] [Reference Citation Analysis]
10 Lv H, Chao C, Wang B, Wang Z, Qian Y, Zhang X. The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ-Ⅲ esophageal cancer: a SEER-based demographic analysis. Cancer Med 2021;10:8483-96. [PMID: 34800005 DOI: 10.1002/cam4.4352] [Reference Citation Analysis]
11 Bakhos CT, Salami AC, Kaiser LR, Petrov RV, Abbas AE. Outcomes of octogenarians with esophageal cancer: an analysis of the National Cancer Database. Dis Esophagus 2019;32:1-8. [PMID: 30596899 DOI: 10.1093/dote/doy128] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Nobel TB, Curry M, Gennarelli R, Jones DR, Molena D. Higher clinical suspicion is needed for prompt diagnosis of esophageal adenocarcinoma in young patients. J Thorac Cardiovasc Surg 2019:S0022-5223(19)30796-2. [PMID: 31126651 DOI: 10.1016/j.jtcvs.2019.03.095] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Liu N, Molena D, Stem M, Blackford AL, Sewell DB, Lidor AO. Underutilization of Treatment for Regional Gastric Cancer Among the Elderly in the USA. J Gastrointest Surg 2018;22:955-63. [PMID: 29404983 DOI: 10.1007/s11605-018-3691-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
14 Delman AM, Ammann AM, Turner KM, Vaysburg DM, Van Haren RM. A narrative review of socioeconomic disparities in the treatment of esophageal cancer. J Thorac Dis 2021;13:3801-8. [PMID: 34277070 DOI: 10.21037/jtd-20-3095] [Reference Citation Analysis]
15 Yang Y, Chen M, Xie J, Ji Y, Sheng L, Qiu G, Du X, Wei Q. Treatment Patterns and Outcomes of Elderly Patients With Potentially Curable Esophageal Cancer. Front Oncol 2022;12:778898. [DOI: 10.3389/fonc.2022.778898] [Reference Citation Analysis]
16 Li X, Zhang J, Ye C, Zhu J, Guo K, Guo Y. Impact of chemotherapy and radiotherapy on the survival of elderly esophageal cancer patients undergoing surgery: a SEER database analysis. BMC Gastroenterol 2021;21:430. [PMID: 34794384 DOI: 10.1186/s12876-021-02016-9] [Reference Citation Analysis]
17 Nobel TB, Molena D. From standardization to personalized medicine: Moving beyond cookie-cutter treatment of esophageal cancer. J Thorac Cardiovasc Surg 2018;156:1736-8. [PMID: 30248805 DOI: 10.1016/j.jtcvs.2018.06.059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Cooper L, Dezube AR, De León LE, Kucukak S, Mazzola E, Dumontier C, Mamon H, Enzinger P, Jaklitsch MT, Frain LN, Wee JO. Outcomes of trimodality CROSS regimen in older adults with locally advanced esophageal cancer. Eur J Surg Oncol 2021:S0748-7983(21)00418-2. [PMID: 33895020 DOI: 10.1016/j.ejso.2021.04.013] [Reference Citation Analysis]
19 Chang JW, Jung DH, Huh CW, Park JC, Shin SK, Lee SK, Lee YC. Long-Term Outcomes and Prognostic Factors of Superficial Esophageal Cancer in Patients Aged ≥ 65 Years. Front Med 2022;8:722141. [DOI: 10.3389/fmed.2021.722141] [Reference Citation Analysis]
20 Barbetta A, Hsu M, Tan KS, Stefanova D, Herman K, Adusumilli PS, Bains MS, Bott MJ, Isbell JM, Janjigian YY, Ku GY, Park BJ, Wu AJ, Jones DR, Molena D. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 2018;155:2710-2721.e3. [PMID: 29548582 DOI: 10.1016/j.jtcvs.2018.01.086] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
21 Guttmann DM, Mitra N, Metz JM, Plastaras J, Feng W, Swisher-McClure S. Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer. J Geriatr Oncol 2018;9:40-6. [PMID: 28887066 DOI: 10.1016/j.jgo.2017.08.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
22 Martin P, O'Leary E, Deady S, Horgan A. The Uptake and Efficacy of Neoadjuvant Therapy in Older Adults with Locally Advanced Esophogastric Cancer. J Gastrointest Cancer 2020;51:893-900. [PMID: 31701400 DOI: 10.1007/s12029-019-00320-y] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Rhodin KE, Raman V, Jawitz OK, Voigt SL, Farrow NE, Harpole DH, Tong BC, D'Amico TA. Patterns of Use of Induction Therapy for T2N0 Esophageal Cancer. Ann Thorac Surg 2021;111:440-7. [PMID: 32681837 DOI: 10.1016/j.athoracsur.2020.05.089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Moreno AC, Zhang N, Verma V, Giordano SH, Lin SH. Treatment disparities affect outcomes for patients with stage I esophageal cancer: a national cancer data base analysis. J Gastrointest Oncol 2019;10:74-84. [PMID: 30788162 DOI: 10.21037/jgo.2018.10.04] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
25 Del Calvo H, Nguyen DT, Chan EY, Chihara R, Graviss EA, Kim MP. Surgery provides improved overall survival in surgically fit octogenarians with esophageal cancer after chemoradiation therapy. J Thorac Dis 2021;13:5875-86. [PMID: 34795936 DOI: 10.21037/jtd-21-928] [Reference Citation Analysis]
26 Tsukada Y, Higashi T, Shimada H, Kikuchi Y, Terahara A. The use of neoadjuvant therapy for resectable locally advanced thoracic esophageal squamous cell carcinoma in an analysis of 5016 patients from 305 designated cancer care hospitals in Japan. Int J Clin Oncol 2018;23:81-91. [PMID: 28795280 DOI: 10.1007/s10147-017-1178-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
27 Walter F, Böckle D, Schmidt-Hegemann NS, Köpple R, Gerum S, Boeck S, Angele M, Belka C, Roeder F. Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis. Radiat Oncol 2018;13:93. [PMID: 29769143 DOI: 10.1186/s13014-018-1044-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
28 Bollschweiler E, Plum P, Mönig SP, Hölscher AH. Current and future treatment options for esophageal cancer in the elderly. Expert Opinion on Pharmacotherapy 2017;18:1001-10. [DOI: 10.1080/14656566.2017.1334764] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 8.4] [Reference Citation Analysis]